InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Trehu Elizabeth, Directeur Médical. Officer active across 1 company, notably Jounce Therapeutics, Inc.. In total, 3 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €24k. History available since 7 January 2022. The latest transaction was filed on 9 January 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Trehu Elizabeth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
4,159 shares@ US$1.1010.0% of flowCommon StockSEC:0001640455-23-000011:0
27,500 shares0Common StockSEC:0001640455-22-000016:0
3,005 shares@ US$7.3081.9% of flowCommon StockSEC:0001640455-22-000011:0
3 of 3 declarations
About Trehu Elizabeth
Elizabeth Trehu is the Chief Medical Officer at Jounce Therapeutics, Inc. She is responsible for overseeing clinical initiatives and the development of new treatments. With a strong background in medicine and research, she plays a crucial role in the scientific direction of the company. Her expertise contributes to the advancement of innovative therapies and improved patient outcomes.
